Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
2
|
| gptkbp:bfsParent |
gptkb:physicist
|
| gptkbp:acquisition |
gptkb:Sanofi
|
| gptkbp:focus |
monoclonal antibodies
|
| gptkbp:founded |
gptkb:2010
|
| gptkbp:founder |
David Chiswell
|
| gptkbp:headquarters |
gptkb:Cambridge,_England
gptkb:Cambridge,_United_Kingdom |
| https://www.w3.org/2000/01/rdf-schema#label |
Kymab
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:notable_products |
K Y1005
|
| gptkbp:products |
K Y1005
|
| gptkbp:type |
private company
|
| gptkbp:website |
www.kymab.com
|